Rankings
▼
Calendar
RCKT Q3 2023 Earnings — Rocket Pharmaceuticals, Inc. Revenue & Financial Results | Market Cap Arena
RCKT
Rocket Pharmaceuticals, Inc.
$572M
Q3 2023 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$0
Gross Profit
$0
Operating Income
-$65M
Net Income
-$62M
EPS (Diluted)
$-0.75
QoQ Revenue Growth
NaN%
Cash Flow
Operating Cash Flow
-$57M
Free Cash Flow
-$62M
Stock-Based Comp.
$10M
Balance Sheet
Total Assets
$599M
Total Liabilities
$58M
Stockholders' Equity
$541M
Cash & Equivalents
$226M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$0
$0
—
Gross Profit
$0
$0
—
Operating Income
-$65M
-$58M
-11.9%
Net Income
-$62M
-$58M
-7.2%
← FY 2023
All Quarters
Q4 2023 →